نتائج البحث

Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity.

• Authors : Prawjaeng J; Siriraj Health Policy Unit, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.; Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand.

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/therapeutic use

• Source: BMC health services research [BMC Health Serv Res] 2023 May 31; Vol. 23 (1), pp. 561. Date of Electronic Publication: 2023 May 31.Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963

تفاصيل العنوان

Patient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDs.

• Authors : Kalweit M; Department of Computer Science, University of Freiburg, Freiburg, Germany.; Burden AM

Subjects: Deep Learning* ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy

• Source: PLoS computational biology [PLoS Comput Biol] 2023 Jun 02; Vol. 19 (6), pp. e1011073. Date of Electronic Publication: 2023 Jun 02 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238922 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

A Study to Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDs

• Source: Phase 3 Study of ASP015K - A Randomized, Double-blind, Placebo-controlled Confirmatory Study of the Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis Who Had an Inadequate Response

تفاصيل العنوان

Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response

• Source: Treatment of Rheumatoid Arthritis With Disease-modifying Antirheumatic Drugs (DMARDs): Predictors of Response

تفاصيل العنوان

A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs

• Source: A Phase 3, Randomized, Active-Controlled, Double-Blind Study Comparing Upadacitinib (ABT-494) to Abatacept in Subjects With Moderately to Severely Active Rheumatoid Arthritis With Inadequate Response

تفاصيل العنوان

Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial.

• Authors : Møller-Bisgaard S; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup, Denmark.; Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark.

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/diagnostic imaging ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy

• Source: Scandinavian journal of rheumatology [Scand J Rheumatol] 2022 Jul; Vol. 51 (4), pp. 268-278. Date of Electronic Publication: 2021 Sep 02.Publisher: Informa Healthcare Country of Publication: England NLM ID: 0321213 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Trends of adverse events and mortality after DMARDs in patients with rheumatoid arthritis: Interrupted time-series analysis.

• Authors : Fang YF; Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan City, Taiwan.; Liu JR

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/adverse effects ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/chemically induced ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy

• Source: Immunity, inflammation and disease [Immun Inflamm Dis] 2022 Jul; Vol. 10 (7), pp. e630.Publisher: John Wiley and Sons Ltd Country of Publication: England NLM ID: 101635460 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

Exploring drug cost and disease outcome in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs in Norway in 2010-2019 - a country with a national tender system for prescription of costly drugs.

• Authors : Brkic A; Research Department, Sorlandet Hospital, Kristiansand, Norway. .; Diamantopoulos AP

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Biological Products*/Biological Products*/Biological Products*/therapeutic use

• Source: BMC health services research [BMC Health Serv Res] 2022 Jan 10; Vol. 22 (1), pp. 48. Date of Electronic Publication: 2022 Jan 10.Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963

تفاصيل العنوان

Predictors of drug survival for biologic and targeted synthetic DMARDs in rheumatoid arthritis: Analysis from the TRA Clinical Electronic Registry.

• Authors : Lin CT; Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan.; Huang WN

Subjects: Abatacept/Abatacept/Abatacept/*therapeutic use ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy ; Pharmaceutical Preparations/Pharmaceutical Preparations/Pharmaceutical Preparations/*chemistry

• Source: PloS one [PLoS One] 2021 Apr 30; Vol. 16 (4), pp. e0250877. Date of Electronic Publication: 2021 Apr 30 (Print Publication: 2021).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

DMARDs-Gut Microbiota Feedback: Implications in the Response to Therapy.

• Authors : Zaragoza-García O; Faculty of Chemical-Biological Sciences, PhD program in Biomedical Sciences, Universidad Autónoma de Guerrero, Chilpancingo, Guerrero 39087, Mexico.; Castro-Alarcón N

Subjects: Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*therapeutic use ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy ; Gastrointestinal Microbiome/Gastrointestinal Microbiome/Gastrointestinal Microbiome/*drug effects

• Source: Biomolecules [Biomolecules] 2020 Oct 24; Vol. 10 (11). Date of Electronic Publication: 2020 Oct 24.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium: Internet ISSN: 2218-273X

تفاصيل العنوان